risperidone has been researched along with flupenthixol in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Matsubara, R | 1 |
| Griffon, N; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P | 1 |
| Möller, HJ | 1 |
| Chagkutip, J; Govitrapong, P; Srikiatkhachorn, A; Turakitwanakan, W | 1 |
| Beneke, M; Dvorak, A; Glaser, T; Hertling, I; Lesch, OM; Mast, O; Philipp, M; Ramskogler, K; Saletu-Zyhlarz, G; Walter, H | 1 |
| Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
| Dose, M; Glaser, T; Lesch, OM; Philipp, M; Schmauss, M | 1 |
| Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Dobmeier, P; Kuhn, K; Scherer, J; Schmaus, W | 1 |
| Kovács, G | 1 |
| Bares, R; Bartels, M; Beneke, M; Glaser, T; Machulla, HJ; Noda, S; Reimold, M; Schaefer, JE; Solbach, C; Wormstall, H | 1 |
| Kissling, W; Lesch, OM; Philipp, M; Ruhrmann, S; Schmauss, M; Seemann, U | 1 |
| Chiang, HL; Liu, CC; Wu, SY | 1 |
| Frey, S; Juckel, G; Linder, R; Stargardt, T | 1 |
| Müller-Spahn, F | 1 |
| Asmal, L; Carr, J; Chiliza, B; du Plessis, S; Emsley, R; Kahn, RS; Kidd, M; Malhotra, AK; Vink, M | 1 |
| Chang, WH; Chen, KC; Chen, PS; Chi, MH; Hsiao, CY; Hui Lee, I; Lee, LT; Yang, YK; Yu, HY | 1 |
| Asmal, L; Carr, J; Chiliza, B; du Plessis, S; Emsley, R; Kidd, M; Vink, M | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Osman, E; Yıldız, M | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bartolome, JM; Langlois, X; Macdonald, GJ; Tresadern, G | 1 |
3 review(s) available for risperidone and flupenthixol
| Article | Year |
|---|---|
Amisulpride: a review of its efficacy in schizophrenia.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Clinical Trials as Topic; Flupenthixol; Haloperidol; Humans; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
Current use of atypical antipsychotics.
Topics: Antipsychotic Agents; Autoreceptors; Brain; Dose-Response Relationship, Drug; Flupenthixol; Haloperidol; Humans; Medication Adherence; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Risperidone; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission; Treatment Outcome | 2002 |
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
8 trial(s) available for risperidone and flupenthixol
| Article | Year |
|---|---|
Flupenthixol versus risperidone: subjective quality of life as an important factor for compliance in chronic schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Double-Blind Method; Female; Flupenthixol; Humans; Male; Middle Aged; Patient Satisfaction; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires; Treatment Outcome | 2003 |
[Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Topics: Antipsychotic Agents; Chronic Disease; Depression; Double-Blind Method; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2003 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
[Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Flupenthixol; Haloperidol; Humans; Incidence; Male; Middle Aged; Muscle Rigidity; Neurologic Examination; Prospective Studies; Risperidone | 2004 |
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
Topics: Adult; Antipsychotic Agents; Corpus Striatum; Female; Flupenthixol; Frontal Lobe; Haloperidol; Humans; Male; Middle Aged; Positron-Emission Tomography; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology | 2007 |
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Data Interpretation, Statistical; Depressive Disorder; Dyskinesia, Drug-Induced; Employment; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Body Mass Index; Brain; Delayed-Action Preparations; Double-Blind Method; Eating; Female; Flupenthixol; Humans; Image Interpretation, Computer-Assisted; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Risperidone; Schizophrenia; South Africa; Young Adult | 2015 |
Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
Topics: Adult; Antipsychotic Agents; Caudate Nucleus; Double-Blind Method; Female; Flupenthixol; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organ Size; Psychiatric Status Rating Scales; Psychotic Disorders; Putamen; Risperidone; Schizophrenia; Schizophrenic Psychology; Software; Treatment Outcome; Young Adult | 2015 |
15 other study(ies) available for risperidone and flupenthixol
| Article | Year |
|---|---|
[A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Chlorpromazine; Clozapine; Dibenzothiepins; Flupenthixol; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Piperidines; Pyrimidinones; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Risperidone | 1993 |
Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
Topics: Animals; Antipsychotic Agents; Calcium; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; DNA Replication; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Glioma; Haloperidol; Humans; Hybrid Cells; Naphthalenes; Neuroblastoma; Pertussis Toxin; Phenothiazines; Pimozide; Pyrrolidines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Risperidone; Salicylamides; Second Messenger Systems; Sulpiride; Tetrahydronaphthalenes; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1996 |
Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Blood Platelets; Case-Control Studies; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Flupenthixol; Humans; Ketanserin; Male; Phenothiazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Spiperone | 2000 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
[Prescription of psychotropic drugs for schizophrenic outpatients in Hungary].
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Cross-Sectional Studies; Drug Prescriptions; Female; Flupenthixol; Humans; Hungary; Male; Middle Aged; Olanzapine; Outpatients; Risperidone; Schizophrenia; Serotonin Antagonists; Surveys and Questionnaires | 2005 |
Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Female; Flupenthixol; Humans; Injections, Intramuscular; Olanzapine; Patient Compliance; Risperidone; Schizophrenia; Secondary Prevention; Treatment Outcome | 2008 |
Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data.
Topics: Adult; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Flupenthixol; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Models, Econometric; Risperidone; Schizophrenia | 2014 |
A comparison of the effectiveness of risperidone, haloperidol and flupentixol long-acting injections in patients with schizophrenia--A nationwide study.
Topics: Adult; Antipsychotic Agents; Drug Delivery Systems; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Statistics, Nonparametric; Treatment Outcome | 2015 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Molecular properties affecting fast dissociation from the D2 receptor.
Topics: Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Drug Design; Humans; Molecular Structure; Receptors, Dopamine D2; Structure-Activity Relationship | 2011 |